Libertyville, IL, United States of America

David M Peters

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David M. Peters: Innovator in Automated Sample Analysis

Introduction

David M. Peters is an accomplished inventor based in Libertyville, IL. With a focus on innovations in sample analysis technology, he holds two patents that reflect his contributions to the field. His work primarily revolves around automated systems designed to enhance the efficiency of sample analysis.

Latest Patents

Peters’ latest patents are centered on "Systems and methods for automated analysis." These patents describe a comprehensive system for conducting sample analysis in an automated manner. The methods involve introducing samples and sample preparation cartridges into an automated system. This system is capable of isolating and purifying analytes such as nucleic acids and proteins present in the samples. The innovative aspect of this system allows for continuous operator access during the replenishment or removal of various components, thereby increasing operational efficiency.

Career Highlights

David M. Peters is currently employed at Abbott Molecular Inc., where he applies his expertise in developing advanced technologies for scientific analysis. His innovative contributions have positioned him as a key figure in his organization, enhancing the capabilities of the company in the realm of molecular diagnostics and research.

Collaborations

Throughout his career, Peters has collaborated with notable colleagues, including Jason E. Bryant and Daniel P. Casazza. These partnerships have fostered a collaborative environment, leading to significant advancements in the field of automated analysis.

Conclusion

David M. Peters exemplifies the spirit of innovation in the field of automated sample analysis. With his patented technologies, he has made significant strides in improving efficiency and effectiveness, contributing to advancements in scientific research and diagnostics. His work at Abbott Molecular Inc. and collaborations with fellow innovators further demonstrate his commitment to driving progress in this important sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…